A Phase 3, Randomized, Parallel-Group, Active-Controlled, Double-Blind Study to Compare the Efficacy and Safety of CT-P10 With MabThera, Each Administered in Combination With Cyclophosphamide, Vincristine, and Prednisone (CVP) in Patients With Advanced Follicular Lymphoma.

Trial Profile

A Phase 3, Randomized, Parallel-Group, Active-Controlled, Double-Blind Study to Compare the Efficacy and Safety of CT-P10 With MabThera, Each Administered in Combination With Cyclophosphamide, Vincristine, and Prednisone (CVP) in Patients With Advanced Follicular Lymphoma.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2013

At a glance

  • Drugs Cyclophosphamide; Prednisolone; Rituximab; Vincristine
  • Indications Follicular lymphoma
  • Focus Pharmacogenomic; Registrational; Therapeutic Use
  • Sponsors Celltrion
  • Most Recent Events

    • 10 Aug 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 23 Jun 2012 Additional location (spain) added as reported by European Clinical Trials Database record.
    • 17 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top